Correlation Between Four Leaf and Nouveau Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Four Leaf and Nouveau Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Four Leaf and Nouveau Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Four Leaf Acquisition and Nouveau Life Pharmaceuticals, you can compare the effects of market volatilities on Four Leaf and Nouveau Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Four Leaf with a short position of Nouveau Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Four Leaf and Nouveau Life.

Diversification Opportunities for Four Leaf and Nouveau Life

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Four and Nouveau is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Four Leaf Acquisition and Nouveau Life Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nouveau Life Pharmac and Four Leaf is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Four Leaf Acquisition are associated (or correlated) with Nouveau Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nouveau Life Pharmac has no effect on the direction of Four Leaf i.e., Four Leaf and Nouveau Life go up and down completely randomly.

Pair Corralation between Four Leaf and Nouveau Life

Given the investment horizon of 90 days Four Leaf Acquisition is expected to under-perform the Nouveau Life. But the stock apears to be less risky and, when comparing its historical volatility, Four Leaf Acquisition is 1344.85 times less risky than Nouveau Life. The stock trades about -0.02 of its potential returns per unit of risk. The Nouveau Life Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Nouveau Life Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.01) from holding Nouveau Life Pharmaceuticals or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Four Leaf Acquisition  vs.  Nouveau Life Pharmaceuticals

 Performance 
       Timeline  
Four Leaf Acquisition 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Four Leaf Acquisition are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Four Leaf is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Nouveau Life Pharmac 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point.

Four Leaf and Nouveau Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Four Leaf and Nouveau Life

The main advantage of trading using opposite Four Leaf and Nouveau Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Four Leaf position performs unexpectedly, Nouveau Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nouveau Life will offset losses from the drop in Nouveau Life's long position.
The idea behind Four Leaf Acquisition and Nouveau Life Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios